Literature DB >> 20236558

Sympatric and allopatric experimental infections of the planorbid snail Gyraulus chinensis with miracidia of Euparyphium albuferensis (Trematoda: Echinostomatidae).

C Muñoz-Antoli1, A Marín, M Trelis, R Toledo, J-G Esteban.   

Abstract

An experimental infection with echinostomatid miracidia in sympatric or 'local' vs. allopatric or 'away' snail combinations, as a model to examine parasite compatibility, was carried out. We employed Euparyphium albuferensis miracidia to infect Gyraulus chinensis snails, from three different natural parks: Albufera (Valencia, Spain); the Ebro Delta (Tarragona, Spain) and Coto de Doñana (Huelva, Spain). Insignificant differences between the three snail strains were noted for the infection rate and the rhythm of daily cercarial production. However, a significantly higher total cercarial production per snail, patent period and life span were observed in local snails. The different infection characteristics in the three G. chinensis strains considered reveal that E. albuferensis miracidia demonstrate local adaptation.

Entities:  

Mesh:

Year:  2010        PMID: 20236558     DOI: 10.1017/S0022149X10000143

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  3 in total

1.  Meta-analysis indicates lack of local adaptation of Schistosoma mansoni to Biomphalaria alexandrina in Egypt.

Authors:  Iman Fathy Abou-El-Naga
Journal:  Parasitol Res       Date:  2014-01-19       Impact factor: 2.289

2.  Intermediate snail hosts of French Fasciola hepatica: Lymnaea neotropica and Lymnaea viatrix are better hosts than local Galba truncatula.

Authors:  R Sanabria; R Mouzet; B Courtioux; P Vignoles; D Rondelaud; G Dreyfuss; J Cabaret; J Romero
Journal:  Parasitol Res       Date:  2012-08-04       Impact factor: 2.289

3.  Local adaptation of the trematode Fasciola hepatica to the snail Galba truncatula.

Authors:  G Dreyfuss; P Vignoles; D Rondelaud
Journal:  Parasite       Date:  2012-08       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.